Italy vs Serbia: Previously treated cases tested for RR-/MDR-TB
Italy
36.0%
in 2024
Serbia
48.0%
in 2024
Italy rank
156th
Serbia rank
153rd
Previously treated cases tested for RR-/MDR-TB over time
- Italy
- Serbia
How they compare
Serbia currently reports 48.0% against 36.0% in Italy, a difference of 12.0%.
That makes Serbia's figure about 1.3 times Italy's.
The two have swapped places 2 times across 15 shared years of data; in 2005 it was Serbia ahead.
Italy ranks 156th and Serbia ranks 153rd of 180 countries.
Across the 3 decades both report, Italy averaged higher in 1 and Serbia in 2.
Head to head by decade
| Decade | Italy | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.5% | 48.3% | 18.8% | Serbia |
| 2010s | 75.7% | 46.3% | 29.3% | Italy |
| 2020s | 23.3% | 33.7% | 10.3% | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Italy or Serbia?
- Serbia, at 48.0% against 36.0% in Italy as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Italy and Serbia?
- 12.0%, with Serbia ahead.
- How many years of comparable data are there for Italy and Serbia?
- 15 years are reported by both, from 2005 to 2024.
- How do Italy and Serbia rank globally for previously treated cases tested for rr-/mdr-tb?
- Italy ranks 156th and Serbia ranks 153rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.